IRIS
DANESE, SILVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.894
NA - Nord America 1.895
AS - Asia 1.037
AF - Africa 19
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 9
Totale 5.876
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.867
SE - Svezia 1.429
SG - Singapore 781
RU - Federazione Russa 602
FI - Finlandia 322
IT - Italia 172
CN - Cina 129
DE - Germania 108
CZ - Repubblica Ceca 74
GB - Regno Unito 57
IE - Irlanda 41
IN - India 36
JP - Giappone 31
CA - Canada 25
FR - Francia 22
NL - Olanda 19
IR - Iran 14
ES - Italia 13
AU - Australia 11
PL - Polonia 10
EU - Europa 9
KR - Corea 9
HK - Hong Kong 8
CH - Svizzera 7
DZ - Algeria 7
EG - Egitto 6
ID - Indonesia 4
MA - Marocco 4
SA - Arabia Saudita 4
UA - Ucraina 4
BE - Belgio 3
BR - Brasile 3
DK - Danimarca 3
KW - Kuwait 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
MX - Messico 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RO - Romania 2
SI - Slovenia 2
VE - Venezuela 2
VN - Vietnam 2
CL - Cile 1
CO - Colombia 1
CU - Cuba 1
HU - Ungheria 1
ME - Montenegro 1
MY - Malesia 1
PH - Filippine 1
TN - Tunisia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 5.876
Salva come PNG Salva come JPEG
Città #
Lawrence 702
Princeton 700
Singapore 454
Moscow 378
Helsinki 315
New York 157
Shanghai 99
Olomouc 73
Milan 41
Dublin 39
Ashburn 38
Borås 29
Boardman 28
London 18
Delhi 16
Seattle 13
Sendagaya 11
Saint Louis 10
Los Angeles 9
Rome 8
St Louis 8
Bologna 7
Lappeenranta 7
Mountain View 7
Nottingham 7
Versailles 7
New Hyde Park 6
Warsaw 6
Pisa 5
Pune 5
Sunderland 5
Sydney 5
Toronto 5
Amsterdam 4
Baltimore 4
Cairo 4
Chennai 4
Dallas 4
Hyderabad 4
Maidstone 4
Naples 4
Nishi-hiranumachō 4
Padova 4
Paris 4
Adelaide 3
Aversa 3
Beijing 3
Berlin 3
Catania 3
Cherchell 3
Columbus 3
Dammam 3
Dongjak-gu 3
Harrisburg 3
Inverigo 3
Kuwait City 3
Malmo 3
Monza 3
Redwood City 3
Rockville 3
San Giovanni Rotondo 3
Spokane 3
Sunnyvale 3
Taipei 3
Vigo 3
Ziefen 3
Zurich 3
Abu Dhabi 2
Aggius 2
Amman 2
Astana 2
Barcelona 2
Barking 2
Barquisimeto 2
Benevento 2
Blida 2
Buenos Aires 2
Buffalo 2
Camogli 2
Cellatica 2
Cergy 2
Chandigarh 2
Collazzone 2
Denpasar 2
Duino 2
Faisalabad 2
Frankfurt am Main 2
Hangzhou 2
Ho Chi Minh City 2
Honjocho 2
Ibaraki 2
Jakarta 2
Jerusalem 2
Jongno-gu 2
Kawasaki 2
Kolding 2
Kolkata 2
Laredo 2
Leeds 2
Limena 2
Totale 3.397
Salva come PNG Salva come JPEG
Nome #
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 88
VAGUS NERVE STIMULATION REDUCES DISEASE ACTIVITY AND MODULATES SERUM AND AUTONOMIC BIOMARKERS IN BIOLOGICREFRACTORY CROHN'S DISEASE 61
Crohn's disease 57
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 57
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 51
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 30
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 27
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience 27
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 24
Endoscopic Vacuum Therapy (EVT) versus Self-Expandable Metal Stent (SEMS) for Anastomotic Leaks after Upper Gastrointestinal Surgery: Systematic Review and Meta-Analysis 23
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 22
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 22
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 22
Endoscopic vacuum therapy versus self-expandable metal stent for treatment of anastomotic leaks < 30 mm following oncologic Ivor-Lewis esophagectomy: a matched case-control study 21
LONG-TERM SAFETY OF VEDOLIZUMAB IN ULCERATIVE COLITIS AND CROHN'S DISEASE: FINAL RESULTS FROM THE GEMINI LTS STUDY 20
Publisher Correction: Crohn's disease 20
Clinical Pathologic Challenge Saxophone Penis: Challenge 19
Colitis, microbiota and colon cancer: an infernal triangle 19
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis 19
Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 19
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 19
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter? 19
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience 18
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease 18
Ustekinumab in the management of Crohn's disease: Expert opinion 18
A snapshot of the ongoing clinical research on COVID-19 18
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 18
LeMann Index Assessment Overtime in Crohn's Disease Patients Treated With Anti TNFs: A Pilot Observational Cohort Study 17
JAK inhibitors: Novel developments in management of ulcerative colitis 17
Application of Artificial Intelligence to Gastroenterology and Hepatology 17
E-health in inflammatory bowel diseases: More challenges than opportunities? 17
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines 17
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials 16
Clinical Pathologic Challenge Saxophone Penis: Challenge 16
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease 16
JAK selectivity: more precision less troubles 16
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients 16
y ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE 16
INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL 16
Colon Staining Efficacy of Methylene Blue MMx (R) 25 mg Modified Release Tablets, Administered As Single Ascending Oral Doses of 150 and 200 mg in Outpatients Colonoscopy 16
Ulcerative Colitis 16
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 15
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 15
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 15
Has IBD specialists' awareness of biosimilar monoclonal antibodies changed? Results from a survey amongst ECCO members 15
Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment 15
PRESENTATION AND SURGICAL INTERVENTIONS FOR CROHN'S DISEASE WITH PERIANAL FISTULA IN THE BIOLOGICS ERA: RESULTS FROM A MULTICENTRE STUDY 15
The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars 15
Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases 15
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 15
Cytapheresis in inflammatory bowel diseases: Current evidence and perspectives 15
Is cytotoxic-associated gene A-positive Helicobacter pylori important? 15
H. pylori gastric infection in rheumatic diseases 15
JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis 15
Colonic diverticular disease 15
JAK inhibition in inflammatory bowel disease 15
The role of diet and lifestyle in early-onset colorectal cancer: A systematic review 15
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey 14
Endoscopic internal drainage versus endoscopic vacuum therapy for upper gastrointestinal leaks: what's the real deal? 14
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 14
The VEGF-VEGF receptor (VEGF-R) pathway is up-regulated and mediates mucosal angiogenesis in human and experimental inflammatory bowel disease (IBD) 14
The effects of vagus nerve stimulation in biologic-refractory Crohn's disease: A prospective clinical trial 14
Helicobacter pylori CagA positive strains determine oxidative DNA damage in gastric cells 14
Clinical Utility of the LeMann Index and Rutgeerts Score to Predict Postoperative Course of Crohn's Disease: A Retrospective Single-Center Cohort Study 14
Risk factor analysis for therapy related adverse events and infections in elder patients with Inflammatory Bowel Disease; An analysis from the IG-IBD aged study 14
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials 14
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents 14
MULTICENTRE COHORT STUDY TO EVALUATE THE NEED FOR RE-INTERVENTION FOLLOWING MULTIMODAL TREATMENT IN CROHNS DISEASE WITH PERIANAL FISTULA 14
Development of Red Flags for Early Referral of Adults With Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative 14
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 14
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 14
Inflammatory bowel disease: estimates from the global burden of disease 2017 study 14
Association between Helicobacter pylori cytotoxic type I strains and migraine with aura 14
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 14
ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology 14
Ulcerative Colitis: A Cinderella Story 14
The biosimilar road in inflammatory bowel disease: The right way? 14
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX (R) FOR MILD-TO-MODERATE ULCERATIVE COLITIS 14
Endoscopic flexible treatment of Zenker's diverticulum : a modification of the needle-knife technique 13
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX (R) for mild-to-moderate ulcerative colitis 13
Enhanced platelet adhesion induces angiogenesis in the IBD microcirculation 13
Head-to-head trials in inflammatory bowel disease: past, present and future 13
BOWEL ULTRASOUND IS ACCURATE IN ASSESSING DISEASE ACTIVITY IN ULCERATIVE COLITIS 13
Infliximab in Steroid-Dependent Ulcerative Colitis: Efficacy and Predictors of Clinical and Endoscopic Remission 13
New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease 13
MULTICENTRE ECCO COLLABORATIVE GROUP STUDY TO EVALUATE THE NEED FOR REINTERVENTION FOLLOWING MULTIMODAL TREATMENT IN CROHN'S DISEASE WITH PERIANAL FISTULA 13
SELF-EXPANDABLE BIODEGRADABLE STENT IN THE MANAGEMENT OF REFRACTORY BENIGN COLORECTAL STRICTURES: PRELIMINARY RESULTS FROM A PILOT STUDY 13
SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY 13
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease 13
Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease 13
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 13
Thrombotic complications in inflammatory bowel disease: A multifactorial etiology 13
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 13
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 13
Dysregulated intracellular redox equilibrium in intestinal lamina propria T cells (LPT) contributes to mucosal inflammation 13
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open 13
A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities 13
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 13
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study 13
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 12
Totale 1.824
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 1 0 0 0 0 0 0 0 0
2021/2022961 0 0 0 810 16 17 7 5 23 23 15 45
2022/20233.362 1.824 645 74 12 14 363 54 136 179 20 13 28
2023/20241.129 31 38 62 52 54 196 26 70 2 45 107 446
2024/20251.202 1.159 43 0 0 0 0 0 0 0 0 0 0
Totale 6.657